Abstract. Gamma-aminobutyric acid (GABA) functions primarily as an inhibitory neurotransmitter through its receptors in the mature central nervous system. The GABA type A receptor π subunit (GABRP) has been identified in the tissues of the reproductive system, particularly in the uterus. In addition, we have previously detected GABRP expression in both human and mouse placentas. To examine the role of GABRP in trophoblastic cell invasion, we constructed a pIRES2-GABRP-EGFP plasmid which was used for the transfection of a human placental cell line derived from first trimester extravillous trophoblasts (HTR-8/SVneo). The number of invaded cells was decreased by GABRP overexpression. Notably, the decrease in the invasive cell number may be due to the increased apoptosis of the HTR-8/SVneo cells following GABRP transfection, which was further confirmed by flow cytometry, reverse transcriptionquantitative polymerase chain reaction (RT-qPCR) and western blot analysis. Based on the increased apoptosis of trophoblastic cells in pregnancies complicated by preeclampsia (PE) and the fact that GABRP promotes the apoptosis of trophoblastic cells, we hypothesized that GABRP expression is increased in the placental tissues from patients with PE compared with that in the normal groups and this hypothesis was confirmed by RT-qPCR and immunohistochemical analysis. Taken together, these findings imply that GABRP plays an important role in placentation and this pathway may be a promising molecular target for the development of novel therapeutic strategies for PE.
Introduction
Gamma-aminobutyric acid (GABA) acts mainly as an inhibitory neurotransmitter at GABA type A (GABA A) receptors to mediate the synaptic inhibition of neuronal activity in the mammalian brain (1) . The GABA A receptor is a heteropentamer, consisting of five subunits that form a chloride ion channel. In addition to being located on central neurons, functional GABA A receptors, particularly the GABA A receptor π subunit (GABRP), have also been found in peripheral tissues, such as the uterus, prostate, ovaries, placenta, gall bladder, lung and small intestine (2, 3) . It has been reported that the assembly of GABRP into a recombinant GABA A receptor may change the sensitivity of the receptor to modulatory agents such as GABA and allopregnanolone (4) . In addition, due to its upregulation in the human endometrium during the window of implantation, GABRP may play an important role in the generation of a receptive endometrium (5) . In our previous study, GABRP was detected in both human and mouse placenta; however, the precise function of GABRP in trophoblastic cells during placentation remains poorly defined (7) .
In the present study, we report that GABRP overexpression may result in the decreased invasion of HTR-8/SVneo cells, possibly induced by elevated apoptosis. It has been suggested that the elevated apoptosis of cytotrophoblasts (CTBs) in preeclampsia (PE) contributes to the placental dysfunction, which is characteristic of this disorder (6) . Given the role of GABRP in enhancing the apoptosis of HTR-8/SVneo trophoblastic cells, we hypothesized that there may be a correlation between GABRP expression and PE. As expected, the results of reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and immunohistochemical analysis revealed that the expression of GABRP was increased in placental tissues from patients with PE compared with that in the normal controls, which may contribute to the shallow trophoblastic invasion and hence, result in the onset of PE. In our laboratory, we have previously demonstrated that the GABRP protein level was decreased in cultured mouse stromal cells during the decidualization process, and that GABA suppressed this procress through GABA A receptors, which suggests that GABRP impaired the remodeling of the decidua (7) . Based on these results, we concluded that GABRP may adversely affect placental function complicated with PE through intrinsic (trophoblastic) factors in combination with extrinsic (maternal uterine) factors. Further studies are warranted to determine whether GABRP has the potential to be used as a biomarker or a therapeutic molecular target for PE.
Materials and methods
Human placental tissue samples. Six placentas from patients with PE and six placentas from normal pregnancies were obtained from patients at the First Affiliated Hospital of Chongqing Medical University (Chongqing, China). The criteria for the diagnosis of severe PE were strictly based on those of the American Congress of Obstetricians and Gynecologists (2002). The study was approved by the Ethics Committee of Chongqing Medical University (Chongqing, China) and informed consent was obtained from all patients. The tissue samples were fixed in buffered formalin (4%, m/v) and embedded in paraffin according to standard procedures.
Immunohistochemistry (IHC) and immumocytochemistry (ICC)
. IHC was performed with a biotin-streptavidin-peroxidase (SP; Zhongshan Goldenbridge, Beijing, China) and 3,3'-diaminobenzidine (DAB; Zhongshan Goldenbridge). The sections (5 mm) were deparaffinized and rehydrated in xylene and ethanol gradients. The slides were boiled in citrate buffer (10 mM citrate sodium, 10 mM citric acid, pH 6.0) in a microwave oven at 92-98˚C for 15 min for antigen retrieval. The sections were then sequentially incubated with 3% H 2 O 2 in methanol for 10 min to quench endogenous peroxidase, and in normal goat serum as the blocking solution for 20 min. The sections were incubated with primary antibodies against GABRP (ab26055; Abcam, Cambridge, UK) or rabbit IgG isotypic control at 4˚C overnight and biotinylated secondary antibody. The sections were then incubated in HRP-streptavidin (Zhongshan Goldenbridge) for 30 min at room temperature and then detected using the chromogenic peroxidase substrate, DAB, and counterstained with hematoxylin.
For ICC staining, the HTR-8/SVneo trophoblastic cells (obtained from Professor H. Wang, Institute of Zoology, Chinese Academy of Sciences, Beijing, China) were cultured on coverslips for 48 h. The coverslips were fixed in 4% paraformaldehyde for 20 min at room temperature, washed in phosphate-buffered saline (PBS) and permeabilized for 10 min with 0.25% Triton-100 in PBS. The cells were then incubated with 1% bovine serum albumin (BSA) in PBS/Tween 20 (PBST) for 30 min to block the non-specific binding of the antibodies. The cells were incubated with primary antibody or rabbit IgG isotype control overnight at 4˚C, and then incubated with a peroxidase-conjugated secondary antibody for 60 min at 37˚C. The slides were stained with DAB and counterstained with hematoxylin.
Cell culture and treatment. An immortalized, first trimester extravillous trophoblast (EVT) cell line, HTR-8/SVneo, which was derived from a short-lived, primary EVT cell line, was used in the present study. The HTR-8/SVneo cells were maintained in RPMI-1640 medium, supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco-BRL, Carlsbad, CA, USA), 100 U/ml penicillin (Beyotime Biotech, Jiangsu, China) and 100 µg/ml streptomycin (Beyotime Biotech) under standard culture conditions (37˚C in a 5% humidified CO 2 incubator). The cells were transiently transfected with full-length GABRP after being seeded onto 35-mm dishes overnight. In order to exogenously express GABRP, the GABRP sequence was sub-cloned into the pIRES2-EGFP plasmid vector. After the GABRP sequence was inserted into the vector, sequencing analysis was conducted to ensure that this vector was capable of specifically expressing GABRP (constructed by Invitrogen, Carlsbad, CA, USA).
Matrigel invasion assay. An invasion assay was performed in Matrigel-coated (BD Biosciences, Bedford, MA, USA) Transwell inserts (6.5 mm; Costar, Cambridge, UK) containing polycarbonate filters with a pore size of 8 µm. Briefly, the inserts were pre-coated with 100 µl Matrigel matrix (1 mg/ml) at 37˚C for 4 h for gelling. The HTR-8/SVneo cells (1x10 5 cells) in 200 µl serum-free medium were plated in the upper chamber, whereas medium with 10% FBS was added to the lower well. After incubating for 24 h, the cells on the Matrigel side of the insert were scraped by a cotton swab. The inserts were then fixed in methanol for 10 min at room temperature and stained with hematoxylin and eosin (H&E; Zhongshan Goldenbridge). The cells which had invaded to the other side of the insert were counted under a light microscope (IX51; Olympus, Tokyo, Japan) in ten random fields at magnification of x200. The assay was repeated three times, and the results are represented as the percentage means of invasion ± standard deviation (SD) compared with the control.
Western blot analysis. The HTR-8/SVneo cells transfected with overexpressing plasmid groups were lysed for protein extraction using RIPA supplemented with phenylmethylsulfonyl fluoride (PMSF) (both from Beyotime Biotech). The Bradford assay (Beyotime Biotech) was used to determine the protein concentration of each sample. Samples containing 50-100 µg of extracted protein were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were transferred to 0.22 µm nitrocellulose membranes and were incubated with primary antibodies against GABRP (ab26055; Abcam); caspase-3 (19677-1-AP; ProteinTech Group, Wuhan, China); cleaved caspase-3 (Asp175; Cell Signaling Technology, Inc., Danvers, MA, USA); Bcl-2 (AP13823c), Bad (AP1314c) and Bax (AP18517a) (all from Abgent, Inc., San Diego, CA, USA); and GAPDH (AP0063; Bioworld Technology, Inc., St. Louis Park, MN, USA) at 1:1,000 dilution. The secondary antibody was goat anti-rabbit IgG (1:1,000; Zhongshan Goldenbridge). All experiments were repeated at least three times.
Flow cytometry (FCM).
The HTR-8/SVneo cells were transiently transfected with overexpressing (pIRES2-EGFP and pIRES2-GABRP-EGFP) plasmid groups and after 72 h, they were harvested using trypsin without EDTA, washed with PBS, resuspended in 1 ml binding buffer, and stained for 15 min with fluorescein isothiocyanate (FITC)-Annexin V and propidium iodide (PI) in the dark at room temperature, according to the manufacturer's instructions. Cell analysis was performed by a flow cytometer (FACScan) equipped with CellQuest software (both from BD Biosciences). The cells were sorted into living, necrotic, early apoptotic and late apoptotic cells. The relative ratio of early and late apoptotic cells was calculated for further comparison. This assay was repeated at least three times.
RT-qPCR.
Total RNA extraction from the placental tissues and the HTR-8/SVneo cells was performed using TRIzol reagent (Invitrogen) according to the manufacturer's instructions, and quantities of RNA were determined using a spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 260 nm. Two micrograms of total RNA was reverse transcribed using SuperScript III Reverse Transcriptase (Invitrogen).
qPCR was performed using SYBR Premix Ex Taq II (RR820A; Takara Bio, Inc., Kusatsu, Japan) in a CFX96™ Real-Time PCR detection system (Bio-Rad, Berkeley, CA, USA) and analyzed using the ΔΔCt Cell viability assay. A Cell Counting Kit-8 (CCK-8; Beyotime Biotech) was employed in this experiment to quantitatively evaluate cell viability. Following 24, 48 and 72 h of plasmid transfection, a CCK-8 assay was performed using the HTR-8/SVneo cells. Briefly, the HTR-8/SVneo cells were seeded at 0.5x10 4 /well in 96-well plates. RPMI-1640 culture medium (100 µl/well) was added to 10 µl CCK-8 reagent after 20, 44 and 68 h and incubated at 37˚C for a further 4 h, to form water-soluble formazan. The absorbances at 450 and 630 nm (calibrated wave) were determined using a microplate reader (Multiskan MK33; Thermo Fisher Scientific, Inc.). RPMI-1640 medium containing 10% CCK-8 was used as a control.
The untreated control was set at 100%, and the treated samples were normalized to this value according to the following equation: survival rate (%)=optical density (OD) of the treated cells -OD of blank control/OD of negative control -OD of blank control x 100.
Statistical analysis. The bands from western blot analysis were quantified using ImageJ2x software (http://imagej.net/ ImageJ2). All data are presented as the means ± SD and statistical analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA). Furthermore, P<0.05 was considered to indicate a statistically significant difference.
Results

GABRP expression in HTR-8/SVneo cells.
To assess the localization pattern of GABRP within the cells, immunocytochemical analysis was performed on the HTR-8/SVneo trophoblastic cells (Fig. 1) . The presence of GABRP was identified by the specific brown-colored staining of the cytoplasm and the nuclear membrane of the HTR-8/SVneo cells. Notably, GABRP expression was mainly located on the apical side of the nuclear membrane which showed particular polarization to a certain extent.
GABRP overexpression significantly inhibits the invasion of HTR-8/SVneo cells.
GABRP expression in the trophoblastic cell line may play a role in controlling trophoblastic cell invasion. Thus, we constructed a pIRES2-GABRP-EGFP plasmid and used Matrigel cell invasion models in the HTR-8/SVneo cells to verify this assumption. As shown in Fig. 2A , the exogenous expression of GABRP was evaluated by RT-qPCR and western blot analysis. The results demonstrated that the number of invading HTR-8/ SVneo cells overexpressing GABRP was decreased compared with that in the control groups (P<0.05) (Fig. 2B) .
GABRP overexpression decreases cell viability and promotes the apoptosis of HTR-8/SVneo cells.
To determine whether the observed changes in invasiveness were due to the effects of GABRP on cell apoptosis and/or viability, we examined the effects of GABRP on the viability and apoptosis of trophoblastic cells. The HTR-8/SVneo cells transfected with the pIRES2-GABRP-EGFP plasmid were subjected to the CCK-8 assay and FCM, respectively. Compared with the control groups, the viability of the HTR-8/SVneo cells was decreased (P<0.05) (Fig. 3A) and the proportion of apoptotic HTR-8/SVneo cells was increased (Fig. 3B) by GABRP 72 h after transfection.
Members of the Bcl-2 family mediate increased apoptosis of HTR-8/SVneo cells through GABRP overexpression.
As members of the Bcl-2 family are the key regulators of apoptosis, we evaluated the expression of three important members of the family, namely Bcl-2, Bad and Bax. The mRNA levels of pro-apoptotic Bad and Bax were upregulated after GABRP transfection (P<0.05) (Fig. 4A) , which was consistent with the protein levels (P<0.05) (Fig. 4B) . Unexpectedly, the mRNA and protein levels of anti-apoptotic Bcl-2 were also upregulated (P<0.05) (Fig. 4A and B) . Further evaluation by western blot analysis revealed that GABRP overexpression increased the protein expression of cleaved caspase-3 (active form) and caspase-3 (inactive form) (P<0.05) (Fig. 4C) .
GABRP is upregulated in placental villi from patients with PE. The apoptosis of villous trophoblasts is increased in PE
and it is generally believed that PE is associated with impaired trophoblast invasion (8, 9) . Thus, we hypothesized that GABRP may be involved in the onset of PE and we collected placental villi from patients with PE and from normal pregnancy controls of similar gestational stages for IHC analysis and RT-qPCR. Immunoreactivity for GABRP was consistently found in the villous syncytiotrophoblasts (STB) and CTBs of both groups. However, GABRP was strongly expressed in the PE group compared with the normal control group (Fig. 5A) . Compared with the normal control group, the mRNA expression of GABRP was upregulated in the PE group (P<0.05) (Fig. 5B) .
Discussion
Apoptosis is an essential feature of normal placental development; however, it may also be involved in the pathophysiology of pregnancy-related diseases, such as PE (10) . Although the apoptosis of trophoblastic cells increases in normal placentas with advancing gestation, increased apoptosis of trophoblastic cells has been observed in pregnancies complicated by PE (11, 12) . The precise etiology of PE remains unclear; however, it may be associated with shallow trophoblastic invasion or impaired decidualization. In our previous study, we suggested that GABRP impaired remodeling of the decidua (7), and in the present study, we have demonstrated that GABRP promotes apoptosis and hence, inhibits the invasion of trophoblastic cells. Based on these findings, we hypothesized that GABRP may be a novel candidate which explains the association between the pathologies of the fetal placenta and maternal decidua in PE, and GABRP may adversely affect placental function through intrinsic (trophoblastic) factors in combination with extrinsic (maternal uterine) factors.
As important regulators of apoptosis, members of the Bcl-2 family may be divided into two functionally antagonistic groups: i) apoptosis suppressors such as Bcl-2, Bcl-x L and Bcl-w; and ii) apoptosis promoters such as Bax, Bcl-x S , Bak and Bad (13) (14) (15) . To identify the members of this protein family that may regulate trophoblast apoptosis, we assessed the expression of three important members of the Bcl-2 gene family in GABRP-overexpressing HTR-8/SVneo cells. As expected, the mRNA and protein expression of pro-apoptotic Bad and Bax was upregulated following GABRP overexpression. Unexpectedly, the anti-apoptotic Bcl-2 expression was also increased. It appears contradictory that GABRP activates both suppressors and promoters of apoptosis during the apoptosis cascade of HTR-8/SVneo cells. Even though it has been demonstrated that Bcl-2 may inhibit further propagation of the death signal at the mitochondrial level through mediating the activity of initiator caspases and the activation of execution caspases (16, 17) , the increase in Bcl-2 following GABRP overexpression in the HTR-8/SVneo cells appears inadequate to prevent the whole apoptosis cascade when the execution caspases, such as caspase-3 and its active form, cleaved caspase-3, were also activated. Thus, we hypothesized that GABRP maintains a state of equilibrium between anti-apoptotic Bcl-2 and pro-apoptotic Bad. However, excessive GABRP may damage this balance and induce apoptosis along the Bad pathway (Fig. 6A ). In addition, as Bcl-2 expression is STB-specific during pregnancy (18) (19) (20) (21) (22) , it is tempting to speculate that Bcl-2 is associated with the differentiation of trophoblasts. In addition, the treatment of JEG-3 cells with 8-Br-cAMP, which induces genes characteristic of STBs, was shown to raise Bcl-2 protein levels approximately 2-fold (23) . Thus, we speculate that: i) there is a differentiation-dependent pattern of Bcl-2 expression in the placenta, with the protein being expressed in the STBs throughout gestation and increased in JEG-3 choriocarcinoma cells following treatment with the differentiation inducing reagent, 8-Br-cAMP; and ii) Bcl-2 expression establishes a delicate balance between the differentiation and apoptosis of trophoblasts and this may be one mechanism through which trophoblast mass is preserved during pregnancy (Fig. 6B) . In fact, there is evidence to suggest that syncytial fusion is directly or indirectly associated with apoptotic events (24) , and Bcl-2 is involved in the retardation of the apoptosis cascade in the execution stages. In the initiation stages of the apoptosis cascade, caspase-8 is believed to be required for syncytial fusion (25, 26) . Nevertheless, the presumption that GABRP may be involved in the differentiation of trophoblasts through the upregulation of Bcl-2 merits further investigation. . Schematic depicting the effect of gamma-aminobutyric acid type A receptor π subunit (GABRP) on members of the Bcl-2 family in the apoptosis cascade and the role of Bcl-2 in balancing the apoptosis and differentiation process. (A) GABRP maintains the balance between pro-apoptotic Bad and anti-apoptotic Bcl-2 under normal conditions. However, the balance may be lost and biased towards the pro-apoptotic Bad pathway when GABRP is overexpressed. Thereafter, Bax is activated which causes cytochrome c release and activation of the caspase-mediated apoptosis cascade. (B) There is a differentiation-dependent pattern of Bcl-2 expression in the placenta whereby a signal balance between apoptosis and differentiation is achieved and hence, trophoblast mass is preserved during pregnancy.
In mammalian brains, the synaptic inhibition of neuronal activity is principally mediated by GABA at GABA A receptors, and functional GABA A receptors have also been detected in nonneuronal cells (1). Among 16 known GABA A receptor subunits, GABRP mRNA was confirmed to be highly expressed in the human uterus as well as in normal breast tissue by RT-qPCR (2). In fact, there have been many studies regarding the role of GABRP in uterine and breast tissues. For example, GABRP mRNA expression and membrane translocation were suggested to be regulated by HOXA10, which is likely to be involved in initiating and maintaining a receptive endometrium (5) . Furthermore, the dynamic expression of GABRP mRNA throughout pregnancy is suggested to correlate with parturition (4) . Despite the abundance of GABRP in breast tissue, the role of GABRP in breast tissue remains controversial according to the findings of different groups. For example, Zafrakas et al postulated that GABRP may exert a tumor-suppressing effects in breast tissue (2), whereas Sizemore et al suggested that GABRP stimulates basal-like breast cancer cell migration through the activation of extracellular-regulated kinase 1/2 (27) and the distinct results may be due to the heterogeneity of breast cancer. In addition to uterine and breast tissues, it has been demonstrated that GABRP is overexpressed in pancreatic tumors (28) and promotes pancreatic cancer growth through GABA stimulation (29) .
Emerging evidence indicates that GABA acts as a tumor signaling molecule in peripheral non-neuronal cells (30) (31) (32) . Given the role of GABRP in the uterus and some tumor tissues, it is important to consider the potential function of GABRP in the trophoblastic cells of the reproductive system, which share a similar capacity to migrate and invade surrounding tissues with malignant cells (33) (34) (35) . Herein, we have demonstrated that GABRP promotes apoptosis and hence, inhibits the invasion of trophoblastic cells, which may be associated with the onset of PE. In addition, the upregulation of GABRP was detected in placental tissues obtained from patients with PE compared with that in normal control placental tissues which is consistent with our hypothesis. This suggests that GABRP may possibly be used as a tissue marker with diagnostic significance in PE. On the other hand, GABRP overexpression may contribute to the progression of PE and GABRP may be a promising molecular target for the development of new therapeutic strategies for PE.
